Management reiterated confidence that the next step is the publication of a draft local coverage determination (LCD) for EsoGuard, following the CAC meeting. Aklog stated, "we are very confident that ...

NEW YORK, July 16, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (LUCD) (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...

Organogenesis (ORGO) and MiMedx (MDXG) traded lower on Friday after the Centers for Medicare & Medicaid Services (CMS) announced the withdrawal of final Local Coverage Determinations (LCDs) related to ...

With our strengthened balance sheet, we are well equipped to successfully navigate the final stages of this process." The CAC panel will discuss the clinical literature related to Local Coverage ...